Embryonic stem cells (ESCs) are an ideal source for cell therapy and regenerative medicine. ESCs must be differentiated prior to their use for therapeutic applications. However, homogeneous differentiation of ESCs in vitro has proven to be challenging. We hypothesized that both biological and mechanical cues contribute to the specific differentiation of ESCs in vivo. This was tested by mimicking the in vivo microenvironment to differentiate ESCs into chondrogenic lineage using highly elastic polydimethylsiloxane (PDMS) scaffolds and the application of mechanical compression in vitro. ESCs seeded in PDMS scaffolds subjected to static compressive stress resulted in significant upregulation of genes, Sox9, Col2, and Acan, involved in early chondrogenic differentiation. However, the compressive stress did not affect expression of the late hypertrophic markers, Runx2, Col10, and Mmp13, signifying induction of ESCs into early chondroprogenitors. Application of mechanical stress increased expression of mechanical signaling genes, Rhoa, Yap, and Taz. The chondroinductive role of Rhoa was confirmed by the inhibition of RhoA signaling by CCG-1423, which resulted in decreased transcriptional and translational expression of chondrogenic markers. Based on these findings, we proposed a strategy for compression induced chondrogenic differentiation in mechanotransductive 3-D PDMS scaffolds.
Cartilage damage resulting from trauma, inheritance, or aging is a major public health problem. One of such diseases, osteoarthritis (OA), a progressive degeneration of articulate cartilage, affects over 30 million adults over the age of 25 years old in the United States [1, 2] . Numerous factors have been implicated in the pathogenesis of OA including changes in the extracellular matrix (ECM) composition and structure, genetic factors, and mechanical signaling [3] . Cartilage tissue is composed of a low number of chondrocytes, which rarely proliferate and are responsible for the synthesis and production of ECM, comprised primarily of chondrogenic proteins, aggrecan (Acan) and collagen type II (Col2) [3] . Low number of chondrocytes and loss of activity due to aging and other factors, affects their biosynthetic role in cartilage regeneration, thus enhancing the degenerative process [4] . In addition, regeneration is limited due to the avascular and
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aneural nature of cartilage tissues [5, 6] . Currently there is no cure for cartilage dysfunctions. Non-surgical treatments including nonsteroidal anti-inflammatory drugs or intra-articular injections, are merely palliative and do not repair or halt the degeneration process [7] . While surgical treatment options involving debridement or microfracture have been shown to aid in short-term pain management, long-term success is often poor [8] . Alternative strategies such as joint replacements have a potential risk of further complications, including infections and implant failure [9] .
More recently, cartilage defects have been treated using autograft cartilage transplantation. However these approaches are limited by the availability of tissue and donor site morbidity [2] . In addition, successful transplantation requires integration of grafts with comparable strength for restoration of tissue function. Treatment using cartilage autografts often results in production of fibrocartilage, which fails to reproduce the mechanical properties inherent to cartilage and is susceptible to degeneration over time [8] . Due to the limitations of current interventions [10, 11] , cell-based therapies are of great interest to restore the normal composition and function of damaged cartilage. Recently, autologous transplantation of chondrocytes has been used to reverse the symptoms and pathophysiology of OA with modest success [6] . However, chondrocytes have limited expansion capabilities and often de-differentiate during culture in vitro [12, 13] . Embryonic stem cells (ESCs), isolated from the inner cell mass of a pre-implantation blastocyst, capable of unlimited self-renewal and differentiation into any of the 200 types of cells found in the body [14] , are an ideal cell source for cartilage regeneration. Attempts to differentiate ESCs often results in a heterogeneous population of ESC derivatives [15] . However, cell therapies require a population of homogenous derivatives to avoid adverse complications, including teratoma formation [16] . There is a need to develop simple, efficient, and robust methods that yield a uniform population of differentiated ESC derivatives. ESC fate is controlled by complex interactions in the in vivo microenvironment [17] [18] [19] . Furthermore, the importance of mechanotransduction signaling by tension, compressive or shear stress, to determine cell fate during embryogenesis has recently been demonstrated [20] .
As such, mimicking the native microenvironment in vitro, has been shown to improve the maintenance and differentiation of pluripotent ESCs [21] . Extended self-renewal for more than 6 weeks was achieved upon ESC encapsulation in soft self-assembling scaffolds [22] . Varying substrate stiffness was shown to affect ESC differentiation; more elastic and stiffer matrices favored chondrogenic and osteogenic differentiation, respectively [23, 24] . Despite the important role of mechanical signaling in cell fate determination, its role in ESC differentiation has been poorly investigated.
In our study, we utilized 3-D scaffolds to study growth and differentiation of ESCs in response to matrix stiffness and compressive stress [25] . We found that polydimethylsiloxane (PDMS) scaffolds composed of highly interconnected neighboring pores allowed for 3-D migration and proliferation of cells. After a period of growth, ESCs differentiated exhibiting a decrease in pluripotent markers, Oct4, Nanog, and Sox2, and differentiated morphology. When cultured in extended traditional 2-D culture in vitro, ESCs undergo heterogeneous differentiation into various cell types [15] . In contrast, we achieved selective chondrogenic differentiation using compressive stress. The results further demonstrated that application of a one-time only, 24 hour static compression, significantly increased chondrogenic differentiation of ESCs seeded in PDMS scaffolds as evidenced by the increased expression of specific markers. More importantly, compressive stress preferentially caused expression of early progenitor markers, Sox9, Col2, and Acan, but not hypertrophic chondrogenic markers, Runx2, Col10, and Mmp13, which are implicated in OA [26] . This implies that compressive stress efficient induction of ESC differentiation into early chondroprogenitors.
Since mechanotransduction of physical forces including compressive stress can regulate cell shape and fate [27] , we investigated the role of actinomyosin contractility and mechanical signaling by analyzing RhoA [28] , and Yes-associated protein (YAP)/PDZ-binding motif (TAZ) [29] pathways. Upon compressive stress, a concomitant increase in the genes, Rhoa, Yap, and Taz, involved in mechanical signaling and chondrogenic makers, was observed in chondrogenic derivatives of ESCs in the 3-D scaffold microenvironment. To delineate the role of RhoA and YAP signaling pathways in chondrogenic differentiation, ESCs seeded with 3-D PDMS scaffolds were compressed in the presence of a RhoA inhibitor, CCG-1432. Downregulation of RhoA resulted in simultaneous decrease in the transcriptional and translational expression of early chondrogenic markers. This suggests that RhoA signaling is important in the mechanotransduction of compressive signals resulting in chondrogenic differentiation. However, the precise role of RhoA in ESC chondrogenic differentiation warrants further investigation.
In summary, as shown in Figure 1 , we have developed a simple, efficient and robust method for directed differentiation of ESCs into early chondroprogenitors by application of compressive stress. The effect of matrix elasticity and compression on ESCs in 3-D PDMS scaffolds was delineated. Culture in PDMS scaffolds alone, resulted in ESCs seeded in PDMS scaffolds made of elastomer, Ecoflex 30, and incubated for 7 days were compressed (0.05 MPa) for 24 hours and cell fate was analyzed by morphological, biochemical and molecular techniques. Results indicated that the applications of static compressive stress resulted in differentiated morphology, expressed ECM similar to chondroprogenitors, and significantly upregulated expression of both genes and proteins, Sox9, Col2, and Acan, involved in early chondrogenic differentiation. A proposed mechanistic scheme shows that chondrogenic differentiation of ESCs is induced by compressive forces that transduces signals through mechanosensing integrin signaling to the stress fiber, stimulating RhoA, which in turn activates YAP. YAP is then translocated to the nucleus for activation genes for early chondrogenic differentiation. In addition, inhibition of Wnt signaling abrogated expression of hypertrophic genes associated with OA.
slight upregulation of genes involved in chondrogenesis, suggesting a role of substrate elasticity in ESC differentiation [25] . However, application of compressive stress for 24 hours significantly upregulated early chondrogenic markers, Sox9, Col2, and Acan. Further studies implicated that RhoA signaling resulted in increased YAP expression and activation of early chondrogenic genes but not hypertrophic genes. Overall, the method yielded a uniform population of chondroprogenitors derived from ESCs, which could ultimately help in advancing their use for clinical purposes including cell therapy, tissue engineering, and regenerative medicine for cartilage injuries and degenerative diseases.
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